Published in Palliat Med on July 01, 1999
Effectiveness and cost-effectiveness of home palliative care services for adults with advanced illness and their caregivers. Cochrane Database Syst Rev (2013) 5.71
Out-of-hours palliative care: a qualitative study of cancer patients, carers and professionals. Br J Gen Pract (2006) 2.10
The project ENABLE II randomized controlled trial to improve palliative care for rural patients with advanced cancer: baseline findings, methodological challenges, and solutions. Palliat Support Care (2009) 1.76
Recruitment and retention of older adults in aging research. J Am Geriatr Soc (2008) 1.73
Factors affecting recruitment to an observational multicentre palliative care study. BMJ Support Palliat Care (2013) 1.48
Proxy perspectives regarding end-of-life care for persons with cancer. Cancer (2008) 1.21
Quality of life in advanced cancer patients: the impact of sociodemographic and medical characteristics. Br J Cancer (2001) 1.15
Symptom clusters in patients with advanced cancers. Support Care Cancer (2009) 1.12
Evaluation and ethical review of a tool to explore patient preferences for information and involvement in decision making. J Med Ethics (2006) 1.09
Symptom profiles and palliative care in advanced pancreatic cancer: a prospective study. Support Care Cancer (2006) 1.07
Factors associated with attrition from a randomized controlled trial of meaning-centered group psychotherapy for patients with advanced cancer. Psychooncology (2011) 1.00
Health-related quality of life during the last three months of life in patients with advanced cancer. Support Care Cancer (2008) 1.00
Overcoming recruitment challenges in palliative care clinical trials. J Oncol Pract (2013) 0.99
Attrition rates, reasons, and predictive factors in supportive care and palliative oncology clinical trials. Cancer (2012) 0.99
Early participant attrition from clinical trials: role of trial design and logistics. Clin Trials (2008) 0.98
Patient perspectives on participation in the ENABLE II randomized controlled trial of a concurrent oncology palliative care intervention: benefits and burdens. Palliat Med (2012) 0.96
Quality of life in terminal care--with special reference to age, gender and marital status. Support Care Cancer (2005) 0.95
Do rates of mental disorders and existential distress among advanced stage cancer patients increase as death approaches? Psychooncology (2009) 0.93
Developing successful models of cancer palliative care services. Semin Oncol Nurs (2010) 0.91
An assessment of aetiology-based guidelines for the management of nausea and vomiting in patients with advanced cancer. Support Care Cancer (2005) 0.90
[Cannabinoids in palliative care : Systematic review and meta-analysis of efficacy, tolerability and safety]. Schmerz (2016) 0.88
Randomised controlled trial of a new palliative care service: Compliance, recruitment and completeness of follow-up. BMC Palliat Care (2008) 0.88
Planning phase III multi-site clinical trials in palliative care: the role of consecutive cohort audits to identify potential participant populations. Support Care Cancer (2009) 0.87
Recruitment and early retention of women with advanced breast cancer in a complementary and alternative medicine trial. Evid Based Complement Alternat Med (2011) 0.87
The caregiving perspective in heart failure: a population based study. BMC Health Serv Res (2013) 0.83
Reduction in symptoms for homebound patients receiving home-based primary and palliative care. J Palliat Med (2013) 0.82
Discussing prognosis and end-of-life care in the final year of life: a randomised controlled trial of a nurse-led communication support programme for patients and caregivers. BMJ Open (2014) 0.82
Global quality of life in primary caregivers of patients with cancer in palliative phase staying at home. Support Care Cancer (2006) 0.82
Considerations in developing and delivering a non-pharmacological intervention for symptom management in lung cancer: the views of health care professionals. Support Care Cancer (2012) 0.80
Exploring generalizability in a study of costs for community-based palliative care. J Pain Symptom Manage (2011) 0.80
Protocol for a longitudinal qualitative interview study: maintaining psychological well-being in advanced cancer--what can we learn from patients' and carers' own coping strategies? BMJ Open (2013) 0.78
Spiritual beliefs near the end of life: a prospective cohort study of people with cancer receiving palliative care. Psychooncology (2013) 0.78
Patients' experience of oxygen therapy and dyspnea: a qualitative study in home palliative care. Support Care Cancer (2010) 0.77
Glioblastoma multiforme from diagnosis to death: a prospective, hospital-based, cohort, pilot feasibility study of patient reported symptoms and needs. Support Care Cancer (2014) 0.77
An open study of methotrimeprazine in the management of nausea and vomiting in patients with advanced cancer. Support Care Cancer (2005) 0.76
'I'll be in a safe place': a qualitative study of the decisions taken by people with advanced cancer to seek emergency department care. BMJ Open (2016) 0.76
End-of-life care research with bereaved informal caregivers--analysis of recruitment strategy and participation rate from a multi-centre validation study. BMC Palliat Care (2015) 0.75
Coping Well with Advanced Cancer: A Serial Qualitative Interview Study with Patients and Family Carers. PLoS One (2017) 0.75
Psychometric Properties of a Generic, Patient-Centred Palliative Care Outcome Measure of Symptom Burden for People with Progressive Long Term Neurological Conditions. PLoS One (2016) 0.75
Development of a Symptom Management Intervention: Qualitative Feedback From Advanced Lung Cancer Patients and Their Family Caregivers. Cancer Nurs (2016) 0.75
Integration of Early Specialist Palliative Care in Cancer Care: Survey of Oncologists, Oncology Nurses, and Patients. Indian J Palliat Care (2016) 0.75
End-of-life research on patients' attitudes in Germany: a feasibility study. Support Care Cancer (2009) 0.75
Quality of dying and death with cancer in Israel. Support Care Cancer (2014) 0.75
Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 10.03
Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer (1999) 6.76
Polychemotherapy in advanced non small cell lung cancer: a meta-analysis. Lancet (1993) 6.08
Translating health status questionnaires and evaluating their quality: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol (1998) 5.15
The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Eur J Cancer (1994) 3.45
The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 3.40
The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 3.37
Short form 36 (SF-36) health survey: normative data from the general Norwegian population. Scand J Soc Med (1998) 2.53
Quality of life in palliative cancer care: results from a cluster randomized trial. J Clin Oncol (2001) 2.46
A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer (2000) 2.34
Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol (1999) 2.25
Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 2.22
Fatigue in the general Norwegian population: normative data and associations. J Psychosom Res (1998) 2.22
Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. J Clin Oncol (1995) 2.08
Cross-cultural comparisons of the content of SF-36 translations across 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 2.05
Value of repeated blood pressure measurements in children--the Brompton study. Br Med J (1980) 2.05
Cancer patients use of nonproven therapy: a 5-year follow-up study. J Clin Oncol (1998) 2.05
Double data entry: what value, what price? Control Clin Trials (1998) 2.05
Blood pressure in first 10 years of life: the Brompton study. BMJ (1992) 1.97
Translation and performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. I. Data quality, scaling assumptions, reliability, and construct validity. J Clin Epidemiol (1998) 1.93
Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy. Br Med J (Clin Res Ed) (1983) 1.91
Blood pressure survey in a population of newborn infants. Br Med J (1976) 1.87
Testing the equivalence of translations of widely used response choice labels: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 1.86
Clinical pharmacology of methadone for pain. Acta Anaesthesiol Scand (2008) 1.85
Population-based study of dying in hospital in six European countries. Palliat Med (2008) 1.84
A palliative-care intervention and death at home: a cluster randomised trial. Lancet (2000) 1.84
Use of structural equation modeling to test the construct validity of the SF-36 Health Survey in ten countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 1.79
Effect of feeding habit on weight in infancy. Lancet (1977) 1.77
The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease. Acta Anaesthesiol Scand (2004) 1.77
Systolic blood pressure in a population of infants in the first year of life: the Brompton study. Pediatrics (1980) 1.64
Start of oral morphine to cancer patients: effective serum morphine concentrations and contribution from morphine-6-glucuronide to the analgesia produced by morphine. Eur J Clin Pharmacol (2000) 1.63
Does use of alternative medicine predict survival from cancer? Eur J Cancer (2003) 1.62
A prospective study of quality of life in head and neck cancer patients. Part II: Longitudinal data. Laryngoscope (2001) 1.61
Using reference data on quality of life--the importance of adjusting for age and gender, exemplified by the EORTC QLQ-C30 (+3). Eur J Cancer (1998) 1.60
Randomised, double-blind, placebo-controlled trial of corticosteroids for the treatment of hyperemesis gravidarum. BJOG (2001) 1.59
Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ=C30 (+ 3). J Clin Oncol (1998) 1.59
Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer (2003) 1.56
Performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. II. A comparison of the SF-36 with disease-specific measures. J Clin Epidemiol (1998) 1.55
The length of consent documents in oncological trials is doubled in twenty years. Ann Oncol (2008) 1.54
A prospective study of quality of life in head and neck cancer patients. Part I: at diagnosis. Laryngoscope (2001) 1.50
Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer. Eur J Cancer (2009) 1.46
Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients. Acta Oncol (1992) 1.45
How to switch from morphine or oxycodone to methadone in cancer patients? a randomised clinical phase II trial. Eur J Cancer (2011) 1.39
[Information and support to cancer patients. Experience from a course for young cancer patients at the Montebello Center]. Tidsskr Nor Laegeforen (1992) 1.39
Psychiatric symptoms and disorders in adolescents with low birth weight. Arch Dis Child Fetal Neonatal Ed (2004) 1.37
Psychological distress in head and neck cancer patients 7-11 years after curative treatment. Br J Cancer (1995) 1.29
Cluster-randomized trials. Palliat Med (2002) 1.28
Quality of life in patients treated for head and neck cancer: a follow-up study 7 to 11 years after radiotherapy. Int J Radiat Oncol Biol Phys (1994) 1.28
Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients. Pain (2011) 1.28
Genetic variability and clinical efficacy of morphine. Acta Anaesthesiol Scand (2005) 1.27
Assessing the consistency of psychometric properties of the HRQoL scales within the EORTC QLQ-C30 across populations by means of the Mokken Scaling Model. Qual Life Res (1999) 1.20
Quality of life in advanced cancer patients: the impact of sociodemographic and medical characteristics. Br J Cancer (2001) 1.15
A prospective study of health-related quality of life, fatigue, anxiety and depression 3-5 years after stem cell transplantation. Bone Marrow Transplant (2004) 1.14
Physical exercise results in the improved subjective well-being of a few or is effective rehabilitation for all cancer patients? Eur J Cancer (2004) 1.13
Lack of concealment may lead to selection bias in cluster randomized trials of palliative care. Palliat Med (2002) 1.11
Use of item response theory to develop a shortened version of the EORTC QLQ-C30 emotional functioning scale. Qual Life Res (2004) 1.10
Measurement of health-related quality of life in multiple myeloma. Nordic Myeloma Study Group. Br J Haematol (1996) 1.09
Psychological distress after cancer cure: a survey of 459 Hodgkin's disease survivors. Br J Cancer (1997) 1.08
Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients. Pharmacogenomics J (2003) 1.06
A prospective multicentre study in Sweden and Norway of mental distress and psychiatric morbidity in head and neck cancer patients. Br J Cancer (1999) 1.06
Survival after balloon atrial septostomy for complete transposition of great arteries. Arch Dis Child (1987) 1.02
Pain assessment tools in palliative care: an urgent need for consensus. Palliat Med (2008) 1.01
Chronic non-malignant pain patients report as poor health-related quality of life as palliative cancer patients. Acta Anaesthesiol Scand (2007) 1.01
Effect of physical exercise on muscle mass and strength in cancer patients during treatment--a systematic review. Crit Rev Oncol Hematol (2013) 1.00
Hodgkin's disease survivors more fatigued than the general population. J Clin Oncol (1999) 1.00
Malnutrition and food intake in relation to quality of life in head and neck cancer patients. Head Neck (1998) 0.98
Prognostic factors and survival in a heterogeneous sample of cancer patients. Br J Cancer (1996) 0.98
Intermediate to late term results of Mustard's procedure for complete transposition of the great arteries with an intact ventricular septum. Br Heart J (1988) 0.97
Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma. European Organization for Research and Treatment of Cancer Study Group on Quality of Life. Br J Haematol (1999) 0.96
High level of fatigue in lymphoma patients treated with high dose therapy. J Pain Symptom Manage (2000) 0.96
A comparison of ondansetron with metoclopramide in the prophylaxis of chemotherapy-induced nausea and vomiting: a randomized, double-blind study. International Emesis Study Group. Eur J Cancer (1990) 0.96
The course of anxiety and depression during the first year after allogeneic or autologous stem cell transplantation. Bone Marrow Transplant (1999) 0.96
Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: a prospective survey in 300 adult cancer patients. Acta Anaesthesiol Scand (2003) 0.96
Classification of pain in cancer patients--a systematic literature review. Palliat Med (2009) 0.95
Reduced health-related quality of life among Hodgkin's disease survivors: a comparative study with general population norms. Ann Oncol (1999) 0.95
Quality of life in adult cancer patients treated with bone marrow transplantation--a review of the literature. Eur J Cancer (1995) 0.95
Why are cancer patients using non-proven complementary therapies? A cross-sectional multicentre study in Norway. Eur J Cancer (1997) 0.94
Effects on cancer patients' health-related quality of life after the start of morphine therapy. J Pain Symptom Manage (2000) 0.94
Attitudes toward informing the cancer patient--a survey of Norwegian physicians. Eur J Cancer (1996) 0.93
Health-related quality of life and its potential prognostic implications in patients with aggressive lymphoma: a Nordic Lymphoma Group Trial. Med Oncol (2001) 0.92
Health-related quality of life 1 year after allogeneic or autologous stem-cell transplantation: a prospective study. J Clin Oncol (1999) 0.91
Factors affecting grief reactions in close family members to individuals who have died of cancer. J Pain Symptom Manage (2001) 0.91